Canakinumab in the Treatment of Gouty Arthritis Flare(s) and Prevention of New Flares in Patients With Chronic Kidney Disease

NCT01593527 · clinicaltrials.gov ↗

PHASE3

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Conditions

Acute Gouty Arthritis

Interventions

DRUG: ACZ885
DRUG: Triamcinelone acetonide

Sponsor

Novartis Pharmaceuticals